Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Interest Expenses (2016 - 2025)

BioCorRx (BICX) has disclosed Interest Expenses for 15 consecutive years, with $70009.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 45.33% to $70009.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $224878.0 through Dec 2025, down 71.05% year-over-year, with the annual reading at $223850.0 for FY2025, 71.18% down from the prior year.
  • Interest Expenses hit $70009.0 in Q4 2025 for BioCorRx, up from $30823.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $543246.0 in Q4 2021 to a low of $870.0 in Q2 2021.
  • Historically, Interest Expenses has averaged $98653.2 across 5 years, with a median of $36723.0 in 2023.
  • Biggest YoY gain for Interest Expenses was 11431.72% in 2022; the steepest drop was 95.63% in 2022.
  • Year by year, Interest Expenses stood at $543246.0 in 2021, then plummeted by 95.63% to $23743.0 in 2022, then skyrocketed by 45.68% to $34588.0 in 2023, then surged by 270.23% to $128054.0 in 2024, then crashed by 45.33% to $70009.0 in 2025.
  • Business Quant data shows Interest Expenses for BICX at $70009.0 in Q4 2025, $30823.0 in Q3 2025, and $36563.0 in Q2 2025.